Weidenbach H, Beckh K, Günthör M, Lerch M M, Adler G
Department of Medicine I, Ulm University Medical School, Germany.
Biochim Biophys Acta. 1995 Oct 19;1245(2):181-6. doi: 10.1016/0304-4165(95)00090-x.
In the liver prostaglandins have been shown to be potent regulators of portal blood flow, carbohydrate metabolism and bile secretion. It is not known whether these effects represent a direct action of prostaglandins, and it has been suggested that nitric oxide (NO) might be a critical mediator for prostaglandin induced hepatic events. We have studied whether nitric oxide formation or inhibition alters the action of prostaglandin F2 alpha (PG F2 alpha) in a single-pass liver perfusion model. The liver of untreated rats (constitutive NO-synthase) or after pretreatment with endotoxin (inducible form of NO-synthase) was perfused at a constant pressure via the portal vein. Effluate were collected in 1-min intervals and bile in 5-min intervals. In both groups the addition of PG F2 alpha (10 microM) to the perfusate for 5 min resulted in a significant increase of glucose and lactate production, and in a significant decrease in portal blood flow (-0.56 +/- 0.04 ml/g per min), in bile flow (-60.7%) and in bile acid release (-60.6%). Inhibition of NO synthase by adding NG-monomethyl-L-arginine (L-NMMA, 100 microM) to the perfusate did not affect any of the alterations induced by PG F2 alpha. Substitution of the endogenous substrate for the NO synthase L-arginine (500 microM) in the perfusate completely prevented the hemodynamic alterations induced by PG F2 alpha in endotoxin pretreated livers and limited the flow reduction (0.15 +/- 0.04 ml/g per min) in the untreated group. The substitution of L-arginine in the perfusate of endotoxin pretreated livers raised nitrite (from 1.5 +/- 0.3 to 3.6 +/- 0.7 nmol/g per min) and urea release (from 65 +/- 25 to 294 +/- 68 nmol/g per min), but had no effect on any of the other metabolic parameters and bile secretion. We conclude that PG F2 alpha increases glucose and lactate production in the perfused rat liver and decreases portal flow bile secretion. The metabolic effects induced by PG F2 alpha appear to be independent of NO mediation and hemodynamic alterations. Portal flow alone can be influenced by endogenous NO formation.
在肝脏中,前列腺素已被证明是门静脉血流、碳水化合物代谢和胆汁分泌的有效调节剂。尚不清楚这些作用是否代表前列腺素的直接作用,并且有人提出一氧化氮(NO)可能是前列腺素诱导的肝脏事件的关键介质。我们研究了一氧化氮的生成或抑制是否会改变前列腺素F2α(PG F2α)在单通道肝脏灌注模型中的作用。通过门静脉以恒定压力灌注未处理大鼠(组成型一氧化氮合酶)或内毒素预处理后(诱导型一氧化氮合酶)的肝脏。每隔1分钟收集流出液,每隔5分钟收集胆汁。在两组中,向灌注液中添加PG F2α(10微摩尔)5分钟导致葡萄糖和乳酸生成显著增加,门静脉血流显著减少(-0.56±0.04毫升/克每分钟),胆汁流量减少(-60.7%)和胆汁酸释放减少(-60.6%)。通过向灌注液中添加NG-单甲基-L-精氨酸(L-NMMA,100微摩尔)抑制一氧化氮合酶,并不影响PG F2α诱导的任何改变。在灌注液中用内源性底物替代一氧化氮合酶L-精氨酸(5微摩尔)完全阻止了PG F2α在内毒素预处理肝脏中诱导的血流动力学改变,并限制了未处理组中的血流减少(0.15±0.04毫升/克每分钟)。在内毒素预处理肝脏的灌注液中替代L-精氨酸会增加亚硝酸盐(从1.5±0.3增加到3.6±0.7纳摩尔/克每分钟)和尿素释放(从65±25增加到294±68纳摩尔/克每分钟),但对任何其他代谢参数和胆汁分泌没有影响。我们得出结论,PG F2α增加灌注大鼠肝脏中的葡萄糖和乳酸生成,并减少门静脉血流和胆汁分泌。PG F2α诱导的代谢作用似乎独立于NO介导和血流动力学改变。仅门静脉血流可受内源性NO生成的影响。